Big Pharma: lessons from the pandemic

Aspen UK

The past two years have been monumental for Big Pharma, yet campaigners continue to highlight the moral ambiguity of profit-making from the discovery, development and marketing of life-saving drugs. Our panellists answer hard hitting questions, including: Has the industry changed for the better, and will these changes stick? Could the industry’s solutions-based model be applied elsewhere? How quickly could we solve the climate crisis or income inequality using this model of public-private partnership, streamlined approval processes, and industry agility?

Join Aspen UK CEO Penny Richards in conversation with Professor Iain Buchan, Associate Pro Vice Chancellor Chair for Innovation at the University of Liverpool, and Danny Sriskandarajah, CEO of Oxfam Great Britain as they discuss the impact of Big Pharma on changing economies and the non-western world, and answer tough questions on the morality of profit-driven healthcare in situations of crisis.

This episode was recorded as a live broadcast at The Good Business Festival on 24 March 2022.

Support the show